Volume 87, Issue 1, 2022-7-1, Pages A9-e51

Articles in this issue:

1. Editorial Board

2. Table of Contents

3. Information for Readers

4. JAAD Case Reports Article List

5. Journal Based CME Instructions and Information

6. Emerging therapeutics in the management of connective tissue disease. Part I. Lupus erythematosus and Sjögren syndrome

7. Emerging therapeutics in the management of connective tissue disease. Part II: Dermatomyositis and scleroderma

8. Letter from the editor: More on meta-analysis

9. This Month in JAAD: July 2022

10. This month in JAAD Case Reports: July 2022: Eyelid ptosis treated with brimonidine gel

11. This month in JAAD International: July 2022: Adverse pregnancy outcomes and psoriasis

12. Multifaceted mucous membrane pemphigoid

13. Insights into clinical and diagnostic findings as well as treatment responses in patients with mucous membrane pemphigoid: A retrospective cohort study

14. Gliptin-associated bullous pemphigoid shows peculiar features of anti-BP180 and -BP230 humoral response: Results of a multicenter study

15. Risk factors for metastatic cutaneous squamous cell carcinoma: Refinement and replication based on 2 nationwide nested case-control studies

16. Increased relative proportions of advanced melanoma among veterans: A comparative analysis with the Surveillance, Epidemiology, and End Results registry

17. Significant improvement of facial actinic keratoses after blue light photodynamic therapy with oral vitamin D pretreatment: An interventional cohort-controlled trial

18. Adjuvant radiation following clear margin resection of high T-stage cutaneous squamous cell carcinoma halves the risk of local and locoregional recurrence: A dual-center retrospective study

19. A multicenter, randomized, double-blinded, placebo-controlled, dose-ranging study evaluating the efficacy and safety of vunakizumab in patients with moderate-to-severe plaque psoriasis

20. Comparing the efficacy and safety of laser treatments in tattoo removal: A systematic review

21. Biologic treatment outcomes in mucous membrane pemphigoid: A systematic review

22. Clinical impact of immunotherapy in Merkel cell carcinoma patients: A systematic review and meta-analysis

23. Efficacy of nonexcisional treatment modalities for superficially invasive and in situ squamous cell carcinoma: A systematic review and meta-analysis

24. Reproductive and hormonal factors and risk of incident rosacea among US White women

25. Mental health outcomes and their association to race and ethnicity in acne patients: A population-based study

26. Geographic variation of iPLEDGE-participating pharmacies across major metropolitan cities in the United States

27. Hydroxychloroquine for generalized granuloma annulare: 35% response rate in a retrospective case series of 26 patients

28. Quantification of adverse skin reactions secondary to mask wearing using 3-dimensional imaging technology: A prospective cohort study

29. Evidence of N-acetylcysteine efficacy for skin picking disorder: A retrospective cohort study

30. Topical dapsone for folliculitis decalvans: A retrospective cohort study

31. Association of resilience and perceived stress in patients with alopecia areata: A cross-sectional study

32. National trends in hospitalizations of atopic dermatitis adult patients: A 21-year longitudinal United States population-based study

33. Bias in, bias out: Underreporting and underrepresentation of diverse skin types in machine learning research for skin cancer detection—A scoping review

34. Mohs micrographic surgery for vulvar malignancies: A systematic review

35. Cutaneous vascular anomalies associated with a mosaic variant of AKT3: Genetic analysis continues to refine the diagnosis, nomenclature, and classification of vascular anomalies

36. Analysis of inpatient dermatology consultations in a veterans affairs hospital

37. The effectiveness of an electronic clinical-decision support tool embedded into the patient medical record at the point of care to guide Mohs surgery utilization: A cohort study

38. Evaluating medical student assessment of common dermatologic conditions across Fitzpatrick phototypes and skin of color

39. Acral lentiginous melanoma in the era of immune checkpoint blockade and targeted therapy: A National Cancer Database analysis

40. Clinical features and management of kaposiform hemangioendothelioma and tufted angioma: Similarities and differences

41. Opiate use in dermatology: A population-based study using the National Ambulatory Medical Care Survey in the United States

42. Prognostic value of lymphovascular invasion in early-stage Merkel cell carcinoma: A retrospective analysis in the National Cancer Database

43. Internet searches for Black dermatologists during the social justice movement of 2020

44. Treatment recommendations for nail unit toxicities secondary to targeted cancer therapy based on collective experience and evidence-based literature review

45. Exercise in dermatology: Exercise's influence on skin aging, skin cancer, psoriasis, venous ulcers, and androgenetic alopecia

46. Online learning tool for the acquisition of frozen-section histopathology knowledge

47. Predictors of postdischarge follow-up attendance among hospitalized dermatology patients: Disparities and potential interventions

48. At 180 days hidradenitis suppurativa readmission rate is comparable to heart failure: Analysis of the nationwide readmissions database

49. Evaluating the inclusiveness of common allergens in expanded series patch tests for children in the pediatric allergic contact dermatitis registry

50. The impact of comorbidity identification on outcomes in patients with pyoderma gangrenosum: A retrospective cohort study of previously hospitalized patients

51. Comorbidities associated with granuloma annulare: A case-control study in the All of Us research program

52. Evaluation of synthetic alpha-melanocyte-stimulating hormone analogs: An observational study of unregulated, online-available drugs

53. Methotrexate for generalized granuloma annulare: A 60% response rate in a retrospective case series of 15 patients

54. Hydroxychloroquine dose tapering or discontinuation in cutaneous lupus erythematosus after remission: A retrospective multicenter cohort study of 56 patients

55. Association of sleep disturbances with geriatric age in atopic dermatitis patients

56. Use of chlormethine 0.04% gel for mycosis fungoides after treatment with topical chlormethine 0.02% gel: A phase 2 extension study

57. The effect of rate and temperature on patient-reported pain during local anesthesia injection: A single-blinded, randomized, controlled trial

58. Assessing the diagnosis of “primary cutaneous mantle cell lymphoma”: A systematic review and population-based analysis

59. Distance to diagnosing dermatology provider as a predictor of multiple melanoma diagnoses

60. Male sex, discoid lupus erythematosus, and lower limb involvement are associated with systemic lupus in lupus panniculitis patients: A multicenter case series of 74 patients

61. Clinical features and treatment outcomes of retronychia: A multicenter retrospective analysis in Korea

62. Healthy skin from within: A novel intervention for women experiencing homelessness

63. Systematic review reporting quality within dermatology: Bibliometric trends compared with general medicine and general surgery from 2008 to 2017

64. Characterizing the role of facial hair in gender identity and expression among transgender men

65. Persistent health inequities in self-payment for outpatient dermatology visits

66. Eyelash involvement in frontal fibrosing alopecia: A prospective study

67. The impact of psoriasis and sexual orientation on mental and physical health among adults in the United States

68. Distribution of hypomelanotic macules in tuberous sclerosis complex: A retrospective cohort study

69. Image quality issues in teledermatology: A comparative analysis of artificial intelligence solutions

70. Attrition of topical calcineurin inhibitor use over time in patients with atopic dermatitis

71. Racial and ethnic differences in the surgical treatment of dermatofibrosarcoma protuberans: A retrospective cohort analysis

72. Local recurrence in patients undergoing wide excision and sentinel lymph node biopsy for cutaneous malignant melanoma: A single-center, retrospective cohort analysis

73. Vaccination against human papillomavirus is not associated with resolution of verruca vulgaris in immunocompetent 9- to 21-year olds

74. Ethics of professional courtesy in cosmetic dermatology

75. Suture localization of scalp biopsy sites

76. Minimally invasive curettage: A better method for removing childhood pilomatricomas than surgical excision

77. Pearls for securing the pinch-and-slide suture technique for high-tension closures

78. Using a straight mosquito hemostat for hemostasis in skin tag removal

79. A novel injection technique for the use of deoxycholic acid to mitigate pain while maintaining efficacy

80. Helical rim advancement flap and a diagonal wedge repair for a large ear defect

81. Overlay photography technique to acquire the identical images to evaluate hair loss and treatment response in clinical practice

82. Response to the article by Kwak et al entitled “No increased incidence of Clostridium difficile infection among patients with hidradenitis suppurativa treated with systemic clindamycin”

83. Factors influencing willingness to pay and show images with teledermatology during the COVID19 pandemic

84. From the Cochrane Library: Phototherapy for atopic eczema

85. Response to Avila et al’s “Dermatologist Online Ratings for Botulinum Toxin are Nuanced and May be Misleading”

86. Comment on “Bicalutamide Improves Minoxidil-Induced Hypertrichosis in Female Pattern Hair Loss: A Retrospective Review of 35 Patients”

87. Reply to: “Comment on: Bicalutamide Improves Minoxidil-Induced Hypertrichosis in Female Pattern Hair Loss: A Retrospective Review of 35 Patients”

88. Response to: “Special editorial: When prescribing Janus kinase inhibitors for dermatologic conditions, be mindful of the Food and Drug Administration’s September 1, 2021, data safety communication”

89. Balancing medication cost, safety, and efficacy among Medicare beneficiaries with dermatologic conditions

90. Response to Falotico and Lipner’s “Balancing medication cost, safety, and efficacy among Medicare beneficiaries with dermatologic conditions”

91. Further analysis of skin of color representation in dermatology textbooks used by residents

92. Skin of color representation in dermatology must be intentionally rectified

93. COVID-19 vaccination in patients with immune-mediated inflammatory diseases receiving rituximab: A personalized regimen should be formulated

94. Reply to: “COVID-19 vaccination in IMID patients receiving rituximab: A personalized regimen should be formulated”

95. Comment on “Correlation of basal cell carcinoma subtype with histologically confirmed subclinical extension during Mohs micrographic surgery: A prospective multicenter study”

96. How to improve doctor-patient connection: Using psychology to optimize healthcare interactions